KARENITECIN Drug Record

  • KARENITECIN chembl:CHEMBL1743260 Antineoplastic

    Alternate Names:

    KARENITECIN

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • KARENITECIN   THOP1

    Interaction Score: 10.3

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • KARENITECIN   TOP1

    Interaction Score: 0.65

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Karenitecin, BNP 1350
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TTD

  • TdgClinicalTrial: KARENITECIN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

  • TTD: Karenitecin

    • Version: 2020.06.01

    Alternate Names:
    D02CZK TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1743260

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: